[go: up one dir, main page]

MX2013007006A - Acoplamientos eficientes de peptidos y su uso en la sintesis y aislamiento de una sal trisodica de ciclopenta[g]quinazolina. - Google Patents

Acoplamientos eficientes de peptidos y su uso en la sintesis y aislamiento de una sal trisodica de ciclopenta[g]quinazolina.

Info

Publication number
MX2013007006A
MX2013007006A MX2013007006A MX2013007006A MX2013007006A MX 2013007006 A MX2013007006 A MX 2013007006A MX 2013007006 A MX2013007006 A MX 2013007006A MX 2013007006 A MX2013007006 A MX 2013007006A MX 2013007006 A MX2013007006 A MX 2013007006A
Authority
MX
Mexico
Prior art keywords
synthesis
cyclopenta
isolation
trisodium salt
quinazoline
Prior art date
Application number
MX2013007006A
Other languages
English (en)
Inventor
Alexander James Bridges
Andrew S Thompson
James Alan Kerschen
Thomas Elliott Jacks
Sean Mark Dalziel
James Robert Zeller
Milind D Choubal
Original Assignee
Onyx Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyx Pharma Inc filed Critical Onyx Pharma Inc
Publication of MX2013007006A publication Critical patent/MX2013007006A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
    • C07K1/088—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents containing other elements, e.g. B, Si, As
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896—Compounds having one or more Si-O-acyl linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/10—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se proporciona un nuevo método para la síntesis del ácido L-Glutamil-y-D-Glutámico y su uso en la síntesis del ácido (2R)-((4S)-carboxi-4-(4,N-(((6S)-2-(hidroximetil)-4-oxo-3,4,7,8-t etrahidro-3H-ciclopenta[g]-quinazolin-6-il)-N-(prop-2-inil)amino) benzamido)butanamido)-pentanodioico, 1. También se proporciona un método eficiente para el aislamiento y purificación de la sal trisódica del ácido mencionado anteriormente, 2, en una forma adecuada durante el almacenamiento a largo plazo y el uso en una forma de dosificación parenteral.
MX2013007006A 2010-12-22 2011-12-19 Acoplamientos eficientes de peptidos y su uso en la sintesis y aislamiento de una sal trisodica de ciclopenta[g]quinazolina. MX2013007006A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061459952P 2010-12-22 2010-12-22
PCT/US2011/065752 WO2012087888A2 (en) 2010-12-22 2011-12-19 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt

Publications (1)

Publication Number Publication Date
MX2013007006A true MX2013007006A (es) 2013-07-30

Family

ID=46314794

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007006A MX2013007006A (es) 2010-12-22 2011-12-19 Acoplamientos eficientes de peptidos y su uso en la sintesis y aislamiento de una sal trisodica de ciclopenta[g]quinazolina.

Country Status (17)

Country Link
US (1) US9458188B2 (es)
EP (1) EP2655398B1 (es)
JP (1) JP2014513663A (es)
KR (1) KR20130132481A (es)
CN (1) CN103748106A (es)
AU (1) AU2011349551A1 (es)
BR (1) BR112013015600A2 (es)
CA (1) CA2819510A1 (es)
CO (1) CO6721028A2 (es)
DK (1) DK2655398T3 (es)
EA (1) EA201390635A1 (es)
HU (1) HUE028918T2 (es)
IL (1) IL226452A0 (es)
MX (1) MX2013007006A (es)
SG (1) SG191269A1 (es)
WO (1) WO2012087888A2 (es)
ZA (1) ZA201303821B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104151398A (zh) * 2014-08-06 2014-11-19 四川同晟氨基酸有限公司 一种合成以谷氨酸为首个氨基酸残基二肽的方法
GB201707864D0 (en) * 2017-05-16 2017-06-28 Inst Of Cancer Research: Royal Cancer Hospital Platinum-reistant cancer treatment
CN107236021B (zh) * 2017-06-12 2020-12-01 湖北泓肽生物科技有限公司 一种多肽衍生物的合成方法
WO2019069978A1 (ja) * 2017-10-03 2019-04-11 日産化学株式会社 ペプチド化合物の製造方法
EP3939959A4 (en) * 2019-03-15 2022-11-23 Nissan Chemical Corporation METHOD OF PREPARING A GLYCOSIDE COMPOUND
US12466850B2 (en) * 2019-08-30 2025-11-11 Nissan Chemical Corporation Method for producing peptide compound

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827083D0 (en) * 1988-11-19 1988-12-21 Porton Prod Ltd Trialkylsilyl esters of amino acids & their use in synthesis of peptides
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
DK1420809T3 (da) * 2001-08-31 2011-12-19 Btg Int Ltd Anvendelse af cyclopenta[G]quinazolinderivater til behandling af cancer
GB0121214D0 (en) * 2001-08-31 2001-10-24 Btg Int Ltd Synthetic method
DE60237902D1 (de) * 2001-08-31 2010-11-18 Btg Int Ltd ANTIKREBS-CYCLOPENTAiG CHINAZOLINE-DERIVATE
ATE421322T1 (de) * 2003-04-04 2009-02-15 Novartis Pharma Gmbh Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege
US8466111B2 (en) * 2008-03-18 2013-06-18 Btg International Limited Cyclopenta{G}quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia

Also Published As

Publication number Publication date
CN103748106A (zh) 2014-04-23
AU2011349551A1 (en) 2013-06-27
WO2012087888A2 (en) 2012-06-28
SG191269A1 (en) 2013-07-31
EA201390635A1 (ru) 2014-09-30
CA2819510A1 (en) 2012-06-28
US9458188B2 (en) 2016-10-04
DK2655398T3 (en) 2016-09-26
WO2012087888A3 (en) 2014-03-06
ZA201303821B (en) 2014-04-30
EP2655398A2 (en) 2013-10-30
US20130345423A1 (en) 2013-12-26
BR112013015600A2 (pt) 2018-05-22
IL226452A0 (en) 2013-07-31
EP2655398B1 (en) 2016-08-24
KR20130132481A (ko) 2013-12-04
JP2014513663A (ja) 2014-06-05
HUE028918T2 (en) 2017-01-30
EP2655398A4 (en) 2015-06-17
CO6721028A2 (es) 2013-07-31

Similar Documents

Publication Publication Date Title
BRPI0923728A2 (pt) "método de preparação de compostos de di-hidroindeno amida, suas composições farmacêuticas contendo esses compostos e uso como inibidor de proteína quinase".
MX2013007006A (es) Acoplamientos eficientes de peptidos y su uso en la sintesis y aislamiento de una sal trisodica de ciclopenta[g]quinazolina.
MX2010006799A (es) Benzofuropirimidinonas como inhibidores de la proteina cinasa.
EA201390199A1 (ru) 2-замещенные-8-алкил-7-оксо-7,8-дигидропиридо[2,3-d]пиримидин-6-карбонитрилы и их применение
TW200714589A (en) Phenylacetamides suitable as protein kinase inhibitors
PH12014500122A1 (en) Inhibitors of bruton's tyrosine kinase
EA201070395A1 (ru) Ингибиторы polo-подобных киназ
AR073073A1 (es) Compuestos de pirrolo [ 2,3-d] pirimidina.
WO2009049180A3 (en) Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
JO2885B1 (en) Protein kinase inhibitors
PH12015501484A1 (en) Heteroaryl compounds and uses thereof
MX2010001368A (es) Forma cristalina de la sal diclorhidrato de ((1s)-1-(((2s)-2-(5-(4 ´-(2-((2s)-1-((2s)-2-((metoxicarbonil) amino)-3-metilbutanoil)-2-p irrolidinil)-1h-imidazol-5-il)-4-bifenilil)-1h-imidazol-2-il)-1-p irrolidinil) carbonil)-2-metilpropil)carbamato de
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
MX2008010884A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1.
WO2008059368A3 (en) Fused 2-amino pyrimidine compounds and their use for the treatment of cancer
EA201201081A1 (ru) Производные гетарил[1,8]нафтиридина
MX2009010485A (es) Derivados de imidazolidinacarboxamida como inhibidores de lipasas y fosfolipasas.
WO2011101069A3 (en) 1, 8 -naphthyridines as kinase inhibitors
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
GEP201606522B (en) Inhibitors of nedd8-activating enzyme
TW200624426A (en) BACE inhibitors
UA105788C2 (uk) Натрієва сіль 5-циклопропіл-2-{[2-(2,6-дифторфеніл)піримідин-5-іл]аміно}бензойної кислоти як інгібітори dhodh
CR10052A (es) Proceso para la preparación de aminas
BR112013001721A2 (pt) processo de síntese de compostos de ureia substituída
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal